Hey there! I'm Lucas, the CEO and co-founder of Ayuvant. I'm an entrepreneur with a strong belief that science makes sense only if it is translatable and has a positive impact on society. Ayuvant has cracked the code of delivering RNA medicines, revolutionizing the treatment of cancer and autoimmune diseases.My background is in the development, manufacturing, and commercialization of immunotherapies in big pharmaceutical companies. At a certain point in my career, I realized that disruptive innovation often comes from small teams rather than large corporations. Influenced deeply by my father's experience with chemotherapy toxicity, I pursued a Ph.D. in cancer immunotherapies at Utrecht University, aiming to change the paradigm of cancer treatment. This journey led to the birth of Ayuvant.Together with my co-founder, prof. Gert Storm, we've assembled a top-tier team to ensure that our work at Ayuvant translates into a better life for cancer patients.I'm thrilled to be at the forefront of shaping the future of RNA medicines with Ayuvant. Join me on this journey and discover how we're changing the landscape of cancer treatment.